140 related articles for article (PubMed ID: 1695574)
1. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M
Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574
[TBL] [Abstract][Full Text] [Related]
2. Characterization of D2 dopamine receptors in dopamine-resistant prolactin-secreting rat pituitary tumors 7315a and MtTW15.
Bouvier C; Lagacé G; Lafond J; Beauregard G; Potier M; Collu R
J Neurochem; 1987 Nov; 49(5):1644-50. PubMed ID: 2959753
[TBL] [Abstract][Full Text] [Related]
3. Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labeling.
Amlaiky N; Caron MG
J Neurochem; 1986 Jul; 47(1):196-204. PubMed ID: 2940337
[TBL] [Abstract][Full Text] [Related]
4. Modulation of dopamine receptor agonist binding sites by cations and estradiol in intact pituitary and 7315a tumors.
Abolfathi Z; Di Paolo T
Biochem Pharmacol; 1991 Nov; 42(11):2163-9. PubMed ID: 1958234
[TBL] [Abstract][Full Text] [Related]
5. Tumors producing chronic hyperprolactinemia do not alter [3H]spiperone binding and dopamine turnover in the corpus striatum of the female rat.
Cronin MJ; Reches A; MacLeod RM; Login IS
Eur J Pharmacol; 1983 Jul; 91(2-3):229-34. PubMed ID: 6617744
[TBL] [Abstract][Full Text] [Related]
6. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
Munemura M; Agui T; Sibley DR
Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
[TBL] [Abstract][Full Text] [Related]
7. Immuno-photoaffinity labeling of the D2-dopamine receptor.
Kanety H; Fuchs S
Biochem Biophys Res Commun; 1988 Sep; 155(2):930-6. PubMed ID: 2458727
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
[TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labeling of the D2-dopamine receptor using a novel high affinity radioiodinated probe.
Amlaiky N; Caron MG
J Biol Chem; 1985 Feb; 260(4):1983-6. PubMed ID: 2579064
[TBL] [Abstract][Full Text] [Related]
10. Modulation of dopamine receptors by cations in 7315a, MtTW15 and estradiol-induced pituitary tumors.
Coenen K; Di Paolo T
Biochem Pharmacol; 1990 Sep; 40(6):1373-80. PubMed ID: 2403391
[TBL] [Abstract][Full Text] [Related]
11. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats.
Pilotte NS; Burt DR; Barraclough CA
Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585
[TBL] [Abstract][Full Text] [Related]
12. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
Bouvier C; Forget H; Lagacé G; Drews R; Sinnett D; Labuda D; Collu R
Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
[TBL] [Abstract][Full Text] [Related]
13. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
[TBL] [Abstract][Full Text] [Related]
14. Tetrabenazine has properties of a dopamine receptor antagonist.
Login IS; Cronin MJ; MacLeod RM
Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
[TBL] [Abstract][Full Text] [Related]
15. N-linked oligosaccharides are responsible for rat striatal dopamine D2 receptor heterogeneity.
Clagett-Dame M; McKelvy JF
Arch Biochem Biophys; 1989 Oct; 274(1):145-54. PubMed ID: 2528326
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and guanine nucleotide modulation of dopamine receptor agonist and antagonist binding sites in 7315a pituitary tumors.
Di Paolo T; Bernier MA
Biochem Pharmacol; 1988 Jun; 37(12):2373-9. PubMed ID: 3390204
[TBL] [Abstract][Full Text] [Related]
17. Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
Valerio A; Alberici A; Tinti C; Spano P; Memo M
J Neurochem; 1994 Apr; 62(4):1260-6. PubMed ID: 8133260
[TBL] [Abstract][Full Text] [Related]
18. Structural differences between dopamine D2 receptors present in a rat pituitary adenoma and in transplantable rat pituitary tumors 7315a and MtTW15.
Bouvier C; Lagacé G; Potier M; Collu R
J Neurochem; 1990 Mar; 54(3):815-22. PubMed ID: 1968089
[TBL] [Abstract][Full Text] [Related]
19. Solubilization and characterization of D2-dopamine receptors in an estrone-induced, prolactin-secreting rat pituitary adenoma.
Bouvier C; Potier M; Beauregard G; Lafond J; Amlaiky N; Caron MG; Collu R
J Neurochem; 1986 Nov; 47(5):1653-60. PubMed ID: 3760878
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
